Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis.
MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: an open label study.
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
Transverse myelitis in Behçet's disease: a series of 4 cases and review of the literature.
MicroRNA dysregulation in multiple sclerosis.
Hope for a rare disease: eculizumab in neuromyelitis optica.
ATX-MS-1467 - Positive Immunological data in Multiple Sclerosis: Final Phase I/IIa data shows safety and tolerability, plus efficacy
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports.
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Natalizumab in the pediatric MS population: results of the Italian registry.
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Endovascular Treatment of Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: A retrospective study.
Evidence for classic complement activity in neuromyelitis optica.
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Progressive multiple sclerosis: pathology and pathogenesis.
The medicalisation of revolt: a sociological analysis of medical cannabis users.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Neuroprotective Effects of Oligodendrocyte Progenitor Cell Transplantation in Premature Rat Brain following Hypoxic-Ischemic Injury.
Pages
« first
‹ previous
…
287
288
289
290
291
292
293
294
295
…
next ›
last »